Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

Open access
Mentz, Robert J., Anstrom, Kevin J., Eisenstein, Eric L., Sapp, Shelly, Greene, Stephen J., Morgan, Shelby, Testani, Jeffrey M., Harrington, Amanda H., Sachdev, Vandana, Ketema, Fassil, Kim, Dong-Yun, Desvigne-Nickens, Patrice, Pitt, Bertram, Velazquez, Eric J., TRANSFORM-HF Investigators, Adams, Kirkwood F., Bhatt, Kunal, DeWald, Tracy, Axsom, Kelly M., Murthy, Sandhya, Rich, Jonathan D., Testani, Jeffrey, Smith, Bryan A., Vader, Justin M., McCulloch, Michael D., Skopicki, Hal A., Psotka, Mitchell A., Heroux, Alain L., Lala-Trindade, Anuradha, Stevens, Gerin R., Tang, WH Wilson, Lev, Yair A., William, Preethi, Eberly, Arthur L., Gottleib, Stephen S., Haught, W. Herbert, Grafton, Gillian F., Larned, Joshua M., Tejwani, Lokesh K., Mody, Freny V., Krim, Selim R., Robinson, Monique T., Fang, James C., Adler, Alexander A., Bell, Adrian C., Banerjee, Dipanjan, Ruiz Duque, Ernesto A., Mizyed, Ahmad M., Rommel, John J., Arhinful, Justice S., Goyal, Parag, Hall, Michael E., Hummel, Scott L., Shetty, Sanjay, Haas, Donald C., Vilaro, Juan R., Alexy, Tamas, Herre, John M., Clark, John M., Ambrosy, Andrew P., Gaglianello, Nunzio A., Ramasubbu, Kumudha, Meadows, Judith L., Tabtabai, Sara R., Sherwood, Melody, Hasni, Syed, D'Urso, Michael, Muneer, Basharat, Dunlap, Stephanie H., Davis, William, Friedman, Dennis, Guglin, Maya, Ferguson, Andrew D., Abbate, Antonio, Smart, Frank·2023·JAMA

Abstract

Importance: Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential benefit for torsemide. Objective: To determine whether torsemide results in decreased mortality compared with furosemide among patients hospitalized for heart failure. Design, Setting, and Participants: TRANSFORM-HF was an open-label, pragmatic randomized trial that recruited 2859 participants hospitalized with heart failure (regardless of ejection fraction) at 60 hospitals in the United States. Recruitment occurred from June 2018 through March 2022, with follow-up through 30 months for death and 12 months for hospitalizations. The final date for follow-up data collection was July 2022. Interventions: Loop diuretic strategy of torsemide (n = 1431) or furosemide (n = 1428) with investigator-selected dosage. Main Outcomes and Measures: The primary outcome was all-cause mortality in a time-to-event analysis. There were 5 secondary outcomes with all-cause mortality or all-cause hospitalization and total hospitalizations assessed over 12 months being highest in the hierarchy. The prespecified primary hypothesis was that torsemide would reduce all-cause mortality by 20% compared with furosemide. Results: TRANSFORM-HF randomized 2859 participants with a median age of 65 years (IQR, 56-75), 36.9% were women, and 33.9% were Black. Over a median follow-up of 17.4 months, a total of 113 patients (53 [3.7%] in the torsemide group and 60 [4.2%] in the furosemide group) withdrew consent from the trial prior to completion. Death occurred in 373 of 1431 patients (26.1%) in the torsemide group and 374 of 1428 patients (26.2%) in the furosemide group (hazard ratio, 1.02 [95% CI, 0.89-1.18]). Over 12 months following randomization, all-cause mortality or all-cause hospitalization occurred in 677 patients (47.3%) in the torsemide group and 704 patients (49.3%) in the furosemide group (hazard ratio, 0.92 [95% CI, 0.83-1.02]). There were 940 total hospitalizations among 536 participants in the torsemide group and 987 total hospitalizations among 577 participants in the furosemide group (rate ratio, 0.94 [95% CI, 0.84-1.07]). Results were similar across prespecified subgroups, including among patients with reduced, mildly reduced, or preserved ejection fraction. Conclusions and Relevance: Among patients discharged after hospitalization for heart failure, torsemide compared with furosemide did not result in a significant difference in all-cause mortality over 12 months. However, interpretation of these findings is limited by loss to follow-up and participant crossover and nonadherence. Trial Registration: ClinicalTrials.gov Identifier: NCT03296813

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2022.23924

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 189

Metadata

Authors
Mentz, R. J., Anstrom, K. J., Eisenstein, E. L., Sapp, S., Greene, S. J., Morgan, S., Testani, J. M., Harrington, A. H., Sachdev, V., Ketema, F., Kim, D.-Y., Desvigne-Nickens, P., Pitt, B., Velazquez, E. J., TRANSFORM-HF Investigators, Adams, K. F., Bhatt, K., DeWald, T., Axsom, K. M., Murthy, S., Rich, J. D., Testani, J., Smith, B. A., Vader, J. M., McCulloch, M. D., Skopicki, H. A., Psotka, M. A., Heroux, A. L., Lala-Trindade, A., Stevens, G. R., Tang, W. W., Lev, Y. A., William, P., Eberly, A. L., Gottleib, S. S., Haught, W. H., Grafton, G. F., Larned, J. M., Tejwani, L. K., Mody, F. V., Krim, S. R., Robinson, M. T., Fang, J. C., Adler, A. A., Bell, A. C., Banerjee, D., Ruiz Duque, E. A., Mizyed, A. M., Rommel, J. J., Arhinful, J. S., Goyal, P., Hall, M. E., Hummel, S. L., Shetty, S., Haas, D. C., Vilaro, J. R., Alexy, T., Herre, J. M., Clark, J. M., Ambrosy, A. P., Gaglianello, N. A., Ramasubbu, K., Meadows, J. L., Tabtabai, S. R., Sherwood, M., Hasni, S., D'Urso, M., Muneer, B., Dunlap, S. H., Davis, W., Friedman, D., Guglin, M., Ferguson, A. D., Abbate, A., & Smart, F.
Venue
JAMA
Published
2023-01-17
Volume
329
Issue
3
Pages
214
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4316928453
Cited by
189
References
5
FWCI
32.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2022.23924
The paper
Mentz, R. J., Anstrom, K. J., Eisenstein, E. L., Sapp, S., Greene, S. J., Morgan, S., Testani, J. M., Harrington, A. H., Sachdev, V., Ketema, F., Kim, D.-Y., Desvigne-Nickens, P., Pitt, B., Velazquez, E. J., TRANSFORM-HF Investigators, Adams, K. F., Bhatt, K., DeWald, T., Axsom, K. M., . . . Smart, F. (2023). Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2022.23924

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.